CVS Health (CVS) earnings Q2 2026
CVS Health on Wednesday blew past second-quarter earnings and revenue estimates and raised its 2026 guidance, as its…
Eli Lilly to offer retatrutide access given earlier to just one patient
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
AstraZeneca and Bristol Myers Squibb mull $400 billion deal: Report
A smart acquisition strategy has made Bristol-Meyers, which has bought seven companies since October 2007, a big player…
New Medicaid work rules could leave rare disease patients uninsured
CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories…
Novo Nordisk shares fall after heart medicine trial results
Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart…
The VA is critical to winning the biotech race with China
Biotechnology is rapidly becoming a pillar of national power. The nation that can discover, test, and deploy new…
FedEx is chasing the GLP-1 boom. Why healthcare logistics means big business
The boom in GLP-1 weight-loss drugs and other specialized medicines has created lucrative logistics opportunities in an industry…
U.S. to see higher generic drug prices on tariffs: Indian pharma CEO
A visitor walks next to the logo of the Indian multinational pharmaceutical company Dr. Reddy’s Laboratories during the…
FDA is urged by advocacy group to ban DTC prescription drug ads
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
Eli Lilly will file for approval of retatrutide obesity drug in 2027
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
This is the stock to buy after OpenAI’s AI agent goes rogue in a cybersecurity test
OpenAI’s rogue AI agent reinforced a cybersecurity threat experts have long anticipated — and Jim Cramer said there’s…
Trump’s generic drug tariffs: What it means for patients, drugmakers and prices
President Donald Trump‘s proposed tariffs on imported generic medicines have raised fresh questions about whether low-cost drugmakers can…